Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype

Objective The objective of this study was to characterize patients with extracranial giant cell arteritis with intracranial involvement. Methods In a multicenter retrospective study, we included 31 patients with systemic giant cell arteritis (GCA) with intracranial involvement. Clinical characterist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of neurology 2021-07, Vol.90 (1), p.118-129
Hauptverfasser: Beuker, Carolin, Wankner, Maximilian Christian, Thomas, Christian, Strecker, Jan‐Kolja, Schmidt‐Pogoda, Antje, Schwindt, Wolfram, Schulte‐Mecklenbeck, Andreas, Gross, Catharina, Wiendl, Heinz, Barth, Peter J., Eckert, Bernd, Meinel, Thomas Raphael, Arnold, Marcel, Schaumberg, Jens, Krüger, Schulamith, Deb‐Chatterji, Milani, Magnus, Tim, Röther, Joachim, Minnerup, Jens
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 129
container_issue 1
container_start_page 118
container_title Annals of neurology
container_volume 90
creator Beuker, Carolin
Wankner, Maximilian Christian
Thomas, Christian
Strecker, Jan‐Kolja
Schmidt‐Pogoda, Antje
Schwindt, Wolfram
Schulte‐Mecklenbeck, Andreas
Gross, Catharina
Wiendl, Heinz
Barth, Peter J.
Eckert, Bernd
Meinel, Thomas Raphael
Arnold, Marcel
Schaumberg, Jens
Krüger, Schulamith
Deb‐Chatterji, Milani
Magnus, Tim
Röther, Joachim
Minnerup, Jens
description Objective The objective of this study was to characterize patients with extracranial giant cell arteritis with intracranial involvement. Methods In a multicenter retrospective study, we included 31 patients with systemic giant cell arteritis (GCA) with intracranial involvement. Clinical characteristics, pattern of arterial involvement, and cytokine profiles were assessed. Patients with GCA without intracranial involvement (n = 17), and with intracranial atherosclerosis (n = 25) served as controls. Results Erythrocyte sedimentation rate (ESR) was elevated in 18 patients (69.2%) with and in 16 patients (100%) without intracranial involvement (p = 0.02). Headache was complained by 15 patients (50.0%) with and 13 patients (76.5%) without intracranial involvement (p = 0.03). Posterior circulation arteries were affected in 26 patients (83.9%), anterior circulation arteries in 17 patients (54.8%), and both territories in 12 patients (38.7%). Patients with GCA had vertebral artery stenosis proximal and, in contrast, patients with atherosclerosis distal to the origin of posterior inferior cerebellar artery (PICA). Among patients with GCA with intracranial involvement, 11 patients (37.9%) had a rapid progressive disease course characterized by short‐term recurrent ischemic events. The median modified Rankin Scale (mRS) at follow‐up in these patients was 4 (interquartile range [IQR] = 2.0–6.0) and 4 patients (36.4%) died. Vessel wall expression of IL‐6 and IL‐17 was significantly increased in patients with rapid progressive course. Interpretation Typical characteristics of GCA, headache, and an elevated ESR, are frequently absent in patients with intracranial involvement. However, differentiation of intracranial GCA from atherosclerosis can be facilitated by the typical pattern of vertebral artery stenosis. About one‐third of patients with intracranial GCA had a rapid progressive course with poor outcome. IL‐17 and IL‐6 may represent potential future treatment targets. ANN NEUROL 2021;90:118–129
doi_str_mv 10.1002/ana.26101
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2528437408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2528437408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3881-81f64b8a37530a2f14017cc4fea6d7094919e93a785c73e00a46c4d8188e5b673</originalsourceid><addsrcrecordid>eNp10U1rGzEQBmBRGhon7SF_oAh6aQ62pZV2JR2NyYfBJCFpz8t4dzZRWGtdSWvX-fWR4ySUQk4D4uFFMy8hJ5yNOGPZGByMsoIz_okMeC74UGfSfCYDJgo5zLmQh-QohEfGmEnqCzkUwhiRSzUgm-kDeKgievsE0XaOdg09-xvTmwdnoaUXFlykU2xbOvE7F22gGxsf6Mz9w2Zu3bVrXGLC4GpqY6C3sLJ1u6U3vrv3GIJdI73rF3G7wq_koIE24LfXeUx-n5_9ml4O59cXs-lkPqyE1mkR3hRyoUGoXDDIGi4ZV1UlG4SiVsxIww0aAUrnlRLIGMiikrXmWmO-KJQ4Jj_3uSvf_ekxxHJpQ5WWAYddH8osz7QUSjKd6I__6GPXe5d-l5TMhBLa5Emd7lXluxA8NuXK2yX4bclZuWujTG2UL20k-_01sV8ssX6Xb-dPYLwHG9vi9uOkcnI12Uc-A_xYk80</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542373895</pqid></control><display><type>article</type><title>Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype</title><source>Wiley Online Library All Journals</source><creator>Beuker, Carolin ; Wankner, Maximilian Christian ; Thomas, Christian ; Strecker, Jan‐Kolja ; Schmidt‐Pogoda, Antje ; Schwindt, Wolfram ; Schulte‐Mecklenbeck, Andreas ; Gross, Catharina ; Wiendl, Heinz ; Barth, Peter J. ; Eckert, Bernd ; Meinel, Thomas Raphael ; Arnold, Marcel ; Schaumberg, Jens ; Krüger, Schulamith ; Deb‐Chatterji, Milani ; Magnus, Tim ; Röther, Joachim ; Minnerup, Jens</creator><creatorcontrib>Beuker, Carolin ; Wankner, Maximilian Christian ; Thomas, Christian ; Strecker, Jan‐Kolja ; Schmidt‐Pogoda, Antje ; Schwindt, Wolfram ; Schulte‐Mecklenbeck, Andreas ; Gross, Catharina ; Wiendl, Heinz ; Barth, Peter J. ; Eckert, Bernd ; Meinel, Thomas Raphael ; Arnold, Marcel ; Schaumberg, Jens ; Krüger, Schulamith ; Deb‐Chatterji, Milani ; Magnus, Tim ; Röther, Joachim ; Minnerup, Jens</creatorcontrib><description>Objective The objective of this study was to characterize patients with extracranial giant cell arteritis with intracranial involvement. Methods In a multicenter retrospective study, we included 31 patients with systemic giant cell arteritis (GCA) with intracranial involvement. Clinical characteristics, pattern of arterial involvement, and cytokine profiles were assessed. Patients with GCA without intracranial involvement (n = 17), and with intracranial atherosclerosis (n = 25) served as controls. Results Erythrocyte sedimentation rate (ESR) was elevated in 18 patients (69.2%) with and in 16 patients (100%) without intracranial involvement (p = 0.02). Headache was complained by 15 patients (50.0%) with and 13 patients (76.5%) without intracranial involvement (p = 0.03). Posterior circulation arteries were affected in 26 patients (83.9%), anterior circulation arteries in 17 patients (54.8%), and both territories in 12 patients (38.7%). Patients with GCA had vertebral artery stenosis proximal and, in contrast, patients with atherosclerosis distal to the origin of posterior inferior cerebellar artery (PICA). Among patients with GCA with intracranial involvement, 11 patients (37.9%) had a rapid progressive disease course characterized by short‐term recurrent ischemic events. The median modified Rankin Scale (mRS) at follow‐up in these patients was 4 (interquartile range [IQR] = 2.0–6.0) and 4 patients (36.4%) died. Vessel wall expression of IL‐6 and IL‐17 was significantly increased in patients with rapid progressive course. Interpretation Typical characteristics of GCA, headache, and an elevated ESR, are frequently absent in patients with intracranial involvement. However, differentiation of intracranial GCA from atherosclerosis can be facilitated by the typical pattern of vertebral artery stenosis. About one‐third of patients with intracranial GCA had a rapid progressive course with poor outcome. IL‐17 and IL‐6 may represent potential future treatment targets. ANN NEUROL 2021;90:118–129</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.26101</identifier><identifier>PMID: 33993547</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Arteries ; Arteriosclerosis ; Arteritis ; Atherosclerosis ; Cerebellum ; Cytokines ; Erythrocyte sedimentation rate ; Erythrocytes ; Headache ; Ischemia ; Patients ; Stenosis ; Veins &amp; arteries ; Vertebrae</subject><ispartof>Annals of neurology, 2021-07, Vol.90 (1), p.118-129</ispartof><rights>2021 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3881-81f64b8a37530a2f14017cc4fea6d7094919e93a785c73e00a46c4d8188e5b673</citedby><cites>FETCH-LOGICAL-c3881-81f64b8a37530a2f14017cc4fea6d7094919e93a785c73e00a46c4d8188e5b673</cites><orcidid>0000-0003-3495-0357 ; 0000-0002-0389-6389 ; 0000-0002-0382-5759 ; 0000-0002-0647-9273</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.26101$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.26101$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33993547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beuker, Carolin</creatorcontrib><creatorcontrib>Wankner, Maximilian Christian</creatorcontrib><creatorcontrib>Thomas, Christian</creatorcontrib><creatorcontrib>Strecker, Jan‐Kolja</creatorcontrib><creatorcontrib>Schmidt‐Pogoda, Antje</creatorcontrib><creatorcontrib>Schwindt, Wolfram</creatorcontrib><creatorcontrib>Schulte‐Mecklenbeck, Andreas</creatorcontrib><creatorcontrib>Gross, Catharina</creatorcontrib><creatorcontrib>Wiendl, Heinz</creatorcontrib><creatorcontrib>Barth, Peter J.</creatorcontrib><creatorcontrib>Eckert, Bernd</creatorcontrib><creatorcontrib>Meinel, Thomas Raphael</creatorcontrib><creatorcontrib>Arnold, Marcel</creatorcontrib><creatorcontrib>Schaumberg, Jens</creatorcontrib><creatorcontrib>Krüger, Schulamith</creatorcontrib><creatorcontrib>Deb‐Chatterji, Milani</creatorcontrib><creatorcontrib>Magnus, Tim</creatorcontrib><creatorcontrib>Röther, Joachim</creatorcontrib><creatorcontrib>Minnerup, Jens</creatorcontrib><title>Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Objective The objective of this study was to characterize patients with extracranial giant cell arteritis with intracranial involvement. Methods In a multicenter retrospective study, we included 31 patients with systemic giant cell arteritis (GCA) with intracranial involvement. Clinical characteristics, pattern of arterial involvement, and cytokine profiles were assessed. Patients with GCA without intracranial involvement (n = 17), and with intracranial atherosclerosis (n = 25) served as controls. Results Erythrocyte sedimentation rate (ESR) was elevated in 18 patients (69.2%) with and in 16 patients (100%) without intracranial involvement (p = 0.02). Headache was complained by 15 patients (50.0%) with and 13 patients (76.5%) without intracranial involvement (p = 0.03). Posterior circulation arteries were affected in 26 patients (83.9%), anterior circulation arteries in 17 patients (54.8%), and both territories in 12 patients (38.7%). Patients with GCA had vertebral artery stenosis proximal and, in contrast, patients with atherosclerosis distal to the origin of posterior inferior cerebellar artery (PICA). Among patients with GCA with intracranial involvement, 11 patients (37.9%) had a rapid progressive disease course characterized by short‐term recurrent ischemic events. The median modified Rankin Scale (mRS) at follow‐up in these patients was 4 (interquartile range [IQR] = 2.0–6.0) and 4 patients (36.4%) died. Vessel wall expression of IL‐6 and IL‐17 was significantly increased in patients with rapid progressive course. Interpretation Typical characteristics of GCA, headache, and an elevated ESR, are frequently absent in patients with intracranial involvement. However, differentiation of intracranial GCA from atherosclerosis can be facilitated by the typical pattern of vertebral artery stenosis. About one‐third of patients with intracranial GCA had a rapid progressive course with poor outcome. IL‐17 and IL‐6 may represent potential future treatment targets. ANN NEUROL 2021;90:118–129</description><subject>Arteries</subject><subject>Arteriosclerosis</subject><subject>Arteritis</subject><subject>Atherosclerosis</subject><subject>Cerebellum</subject><subject>Cytokines</subject><subject>Erythrocyte sedimentation rate</subject><subject>Erythrocytes</subject><subject>Headache</subject><subject>Ischemia</subject><subject>Patients</subject><subject>Stenosis</subject><subject>Veins &amp; arteries</subject><subject>Vertebrae</subject><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp10U1rGzEQBmBRGhon7SF_oAh6aQ62pZV2JR2NyYfBJCFpz8t4dzZRWGtdSWvX-fWR4ySUQk4D4uFFMy8hJ5yNOGPZGByMsoIz_okMeC74UGfSfCYDJgo5zLmQh-QohEfGmEnqCzkUwhiRSzUgm-kDeKgievsE0XaOdg09-xvTmwdnoaUXFlykU2xbOvE7F22gGxsf6Mz9w2Zu3bVrXGLC4GpqY6C3sLJ1u6U3vrv3GIJdI73rF3G7wq_koIE24LfXeUx-n5_9ml4O59cXs-lkPqyE1mkR3hRyoUGoXDDIGi4ZV1UlG4SiVsxIww0aAUrnlRLIGMiikrXmWmO-KJQ4Jj_3uSvf_ekxxHJpQ5WWAYddH8osz7QUSjKd6I__6GPXe5d-l5TMhBLa5Emd7lXluxA8NuXK2yX4bclZuWujTG2UL20k-_01sV8ssX6Xb-dPYLwHG9vi9uOkcnI12Uc-A_xYk80</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Beuker, Carolin</creator><creator>Wankner, Maximilian Christian</creator><creator>Thomas, Christian</creator><creator>Strecker, Jan‐Kolja</creator><creator>Schmidt‐Pogoda, Antje</creator><creator>Schwindt, Wolfram</creator><creator>Schulte‐Mecklenbeck, Andreas</creator><creator>Gross, Catharina</creator><creator>Wiendl, Heinz</creator><creator>Barth, Peter J.</creator><creator>Eckert, Bernd</creator><creator>Meinel, Thomas Raphael</creator><creator>Arnold, Marcel</creator><creator>Schaumberg, Jens</creator><creator>Krüger, Schulamith</creator><creator>Deb‐Chatterji, Milani</creator><creator>Magnus, Tim</creator><creator>Röther, Joachim</creator><creator>Minnerup, Jens</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3495-0357</orcidid><orcidid>https://orcid.org/0000-0002-0389-6389</orcidid><orcidid>https://orcid.org/0000-0002-0382-5759</orcidid><orcidid>https://orcid.org/0000-0002-0647-9273</orcidid></search><sort><creationdate>202107</creationdate><title>Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype</title><author>Beuker, Carolin ; Wankner, Maximilian Christian ; Thomas, Christian ; Strecker, Jan‐Kolja ; Schmidt‐Pogoda, Antje ; Schwindt, Wolfram ; Schulte‐Mecklenbeck, Andreas ; Gross, Catharina ; Wiendl, Heinz ; Barth, Peter J. ; Eckert, Bernd ; Meinel, Thomas Raphael ; Arnold, Marcel ; Schaumberg, Jens ; Krüger, Schulamith ; Deb‐Chatterji, Milani ; Magnus, Tim ; Röther, Joachim ; Minnerup, Jens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3881-81f64b8a37530a2f14017cc4fea6d7094919e93a785c73e00a46c4d8188e5b673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Arteries</topic><topic>Arteriosclerosis</topic><topic>Arteritis</topic><topic>Atherosclerosis</topic><topic>Cerebellum</topic><topic>Cytokines</topic><topic>Erythrocyte sedimentation rate</topic><topic>Erythrocytes</topic><topic>Headache</topic><topic>Ischemia</topic><topic>Patients</topic><topic>Stenosis</topic><topic>Veins &amp; arteries</topic><topic>Vertebrae</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beuker, Carolin</creatorcontrib><creatorcontrib>Wankner, Maximilian Christian</creatorcontrib><creatorcontrib>Thomas, Christian</creatorcontrib><creatorcontrib>Strecker, Jan‐Kolja</creatorcontrib><creatorcontrib>Schmidt‐Pogoda, Antje</creatorcontrib><creatorcontrib>Schwindt, Wolfram</creatorcontrib><creatorcontrib>Schulte‐Mecklenbeck, Andreas</creatorcontrib><creatorcontrib>Gross, Catharina</creatorcontrib><creatorcontrib>Wiendl, Heinz</creatorcontrib><creatorcontrib>Barth, Peter J.</creatorcontrib><creatorcontrib>Eckert, Bernd</creatorcontrib><creatorcontrib>Meinel, Thomas Raphael</creatorcontrib><creatorcontrib>Arnold, Marcel</creatorcontrib><creatorcontrib>Schaumberg, Jens</creatorcontrib><creatorcontrib>Krüger, Schulamith</creatorcontrib><creatorcontrib>Deb‐Chatterji, Milani</creatorcontrib><creatorcontrib>Magnus, Tim</creatorcontrib><creatorcontrib>Röther, Joachim</creatorcontrib><creatorcontrib>Minnerup, Jens</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beuker, Carolin</au><au>Wankner, Maximilian Christian</au><au>Thomas, Christian</au><au>Strecker, Jan‐Kolja</au><au>Schmidt‐Pogoda, Antje</au><au>Schwindt, Wolfram</au><au>Schulte‐Mecklenbeck, Andreas</au><au>Gross, Catharina</au><au>Wiendl, Heinz</au><au>Barth, Peter J.</au><au>Eckert, Bernd</au><au>Meinel, Thomas Raphael</au><au>Arnold, Marcel</au><au>Schaumberg, Jens</au><au>Krüger, Schulamith</au><au>Deb‐Chatterji, Milani</au><au>Magnus, Tim</au><au>Röther, Joachim</au><au>Minnerup, Jens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>2021-07</date><risdate>2021</risdate><volume>90</volume><issue>1</issue><spage>118</spage><epage>129</epage><pages>118-129</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><abstract>Objective The objective of this study was to characterize patients with extracranial giant cell arteritis with intracranial involvement. Methods In a multicenter retrospective study, we included 31 patients with systemic giant cell arteritis (GCA) with intracranial involvement. Clinical characteristics, pattern of arterial involvement, and cytokine profiles were assessed. Patients with GCA without intracranial involvement (n = 17), and with intracranial atherosclerosis (n = 25) served as controls. Results Erythrocyte sedimentation rate (ESR) was elevated in 18 patients (69.2%) with and in 16 patients (100%) without intracranial involvement (p = 0.02). Headache was complained by 15 patients (50.0%) with and 13 patients (76.5%) without intracranial involvement (p = 0.03). Posterior circulation arteries were affected in 26 patients (83.9%), anterior circulation arteries in 17 patients (54.8%), and both territories in 12 patients (38.7%). Patients with GCA had vertebral artery stenosis proximal and, in contrast, patients with atherosclerosis distal to the origin of posterior inferior cerebellar artery (PICA). Among patients with GCA with intracranial involvement, 11 patients (37.9%) had a rapid progressive disease course characterized by short‐term recurrent ischemic events. The median modified Rankin Scale (mRS) at follow‐up in these patients was 4 (interquartile range [IQR] = 2.0–6.0) and 4 patients (36.4%) died. Vessel wall expression of IL‐6 and IL‐17 was significantly increased in patients with rapid progressive course. Interpretation Typical characteristics of GCA, headache, and an elevated ESR, are frequently absent in patients with intracranial involvement. However, differentiation of intracranial GCA from atherosclerosis can be facilitated by the typical pattern of vertebral artery stenosis. About one‐third of patients with intracranial GCA had a rapid progressive course with poor outcome. IL‐17 and IL‐6 may represent potential future treatment targets. ANN NEUROL 2021;90:118–129</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33993547</pmid><doi>10.1002/ana.26101</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-3495-0357</orcidid><orcidid>https://orcid.org/0000-0002-0389-6389</orcidid><orcidid>https://orcid.org/0000-0002-0382-5759</orcidid><orcidid>https://orcid.org/0000-0002-0647-9273</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0364-5134
ispartof Annals of neurology, 2021-07, Vol.90 (1), p.118-129
issn 0364-5134
1531-8249
language eng
recordid cdi_proquest_miscellaneous_2528437408
source Wiley Online Library All Journals
subjects Arteries
Arteriosclerosis
Arteritis
Atherosclerosis
Cerebellum
Cytokines
Erythrocyte sedimentation rate
Erythrocytes
Headache
Ischemia
Patients
Stenosis
Veins & arteries
Vertebrae
title Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T13%3A32%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20Extracranial%20Giant%20Cell%20Arteritis%20with%20Intracranial%20Involvement%20and%20its%20Rapidly%20Progressive%20Subtype&rft.jtitle=Annals%20of%20neurology&rft.au=Beuker,%20Carolin&rft.date=2021-07&rft.volume=90&rft.issue=1&rft.spage=118&rft.epage=129&rft.pages=118-129&rft.issn=0364-5134&rft.eissn=1531-8249&rft_id=info:doi/10.1002/ana.26101&rft_dat=%3Cproquest_cross%3E2528437408%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2542373895&rft_id=info:pmid/33993547&rfr_iscdi=true